Novel Life Science Reagents
| Product Name | CAS No. | Specification | Application | Registration |
| Lusutrombopag | 1110766-97-6 | 98+% | ||
| Eribulin Mesylate | 441045-17-6 | 98+% | the treatmnet of breast cancer | Microtubule/Tubulin | Apoptosis | |
| WST-8 | 193149-74-5 | 98+% | ||
| Streptavidin biosimilar | 9013-20-1 | 98+% | Reactive Oxygen Species | | |
| Deruxtecan | 1599440-13-7 | 98+% | ||
| Glecaprevir(ABT-493) | 1365970-03-1 | 98+% | ||
| Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid | 1610413-97-2 | 98+% | ||
| E-64 | 66701-25-5 | 98+% | ||
| AEBSF HCl(AEBSF hydrochloride) | 30827-99-7 | 98+% | ||
| Fluticasone Furoate | 397864-44-7 | 99+% | ||
| Vc-seco-DUBA | 1345681-58-4 | 95+% | ||
| Seco-DUBA | 1227961-59-2 | 98+% | ||
| Sulfo-PDBA-DM4 | 1461704-01-7 | 98+% | ||
| Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br | 2344809-82-9 | 97% | ||
| sulfo-SPDB-DM4 | 1626359-59-8 | 95+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn